LG Chem, Ltd. (KRX:051910)
292,000
-5,500 (-1.85%)
At close: Mar 16, 2026
LG Chem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45,932,167 | 48,699,754 | 55,249,785 | 50,983,251 | 42,599,284 | |
Revenue Growth (YoY) | -5.68% | -11.86% | 8.37% | 19.68% | 41.72% |
Cost of Revenue | 38,122,707 | 41,247,486 | 46,462,272 | 41,121,055 | 31,384,656 |
Gross Profit | 7,809,460 | 7,452,268 | 8,787,513 | 9,862,196 | 11,214,628 |
Selling, General & Admin | 6,608,503 | 6,691,130 | 5,776,792 | 5,995,898 | 5,520,270 |
Research & Development | 669,243 | 575,520 | 474,555 | 375,702 | 255,142 |
Amortization of Goodwill & Intangibles | 469,219 | 367,440 | 322,253 | 220,995 | 168,384 |
Other Operating Expenses | - | - | -676,874 | - | - |
Operating Expenses | 8,275,371 | 8,057,361 | 6,258,317 | 6,882,842 | 6,188,258 |
Operating Income | -465,911 | -605,093 | 2,529,196 | 2,979,354 | 5,026,370 |
Interest Expense | -1,217,460 | -949,172 | -647,232 | -298,308 | -210,982 |
Interest & Investment Income | 331,427 | 360,813 | 341,489 | 254,435 | 83,034 |
Earnings From Equity Investments | -118,330 | -24,943 | -33,311 | -46,215 | 1,543 |
Currency Exchange Gain (Loss) | 331,967 | -536,574 | 466,047 | -163,741 | 42,647 |
Other Non Operating Income (Expenses) | 2,151,935 | 2,428,157 | 75,241 | 11,730 | 240,879 |
EBT Excluding Unusual Items | 1,013,628 | 673,188 | 2,731,430 | 2,737,255 | 5,183,491 |
Gain (Loss) on Sale of Investments | - | - | 4,531 | - | - |
Gain (Loss) on Sale of Assets | -794,299 | -213,662 | -40,987 | -56,350 | -25,898 |
Asset Writedown | -1,975,780 | -790,916 | -204,288 | -37,079 | -328,211 |
Other Unusual Items | -41,540 | - | -8,181 | 2,884 | - |
Pretax Income | -1,780,425 | -309,507 | 2,498,140 | 2,778,292 | 4,892,030 |
Income Tax Expense | 15,998 | 52,755 | 432,501 | 637,124 | 1,235,779 |
Earnings From Continuing Operations | -1,796,423 | -362,262 | 2,065,639 | 2,141,168 | 3,656,251 |
Earnings From Discontinued Operations | 819,360 | 877,273 | -9,952 | 57,428 | 297,653 |
Net Income to Company | -977,063 | 515,011 | 2,055,687 | 2,198,596 | 3,953,904 |
Minority Interest in Earnings | -842,386 | -1,205,865 | -717,875 | -353,233 | -284,117 |
Net Income | -1,819,449 | -690,854 | 1,337,812 | 1,845,363 | 3,669,787 |
Net Income to Common | -1,819,449 | -690,854 | 1,337,812 | 1,845,363 | 3,669,787 |
Net Income Growth | - | - | -27.50% | -49.71% | 615.87% |
Shares Outstanding (Basic) | 78 | 78 | 78 | 78 | 78 |
Shares Outstanding (Diluted) | 78 | 78 | 78 | 78 | 78 |
Shares Change (YoY) | 0.00% | - | 0.42% | 0.07% | 1.36% |
EPS (Basic) | -23244.00 | -8826.00 | 17091.16 | 23675.25 | 47113.25 |
EPS (Diluted) | -23244.00 | -8826.00 | 17091.16 | 23675.25 | 47113.25 |
EPS Growth | - | - | -27.81% | -49.75% | 606.28% |
Free Cash Flow | -5,426,872 | -7,602,524 | -5,423,429 | -7,836,408 | -263,777 |
Free Cash Flow Per Share | -69329.90 | -97125.99 | -69286.77 | -100537.88 | -3386.41 |
Dividend Per Share | - | - | 3500.000 | 10000.000 | 12000.000 |
Dividend Growth | - | - | -65.00% | -16.67% | 20.00% |
Gross Margin | 17.00% | 15.30% | 15.90% | 19.34% | 26.33% |
Operating Margin | -1.01% | -1.24% | 4.58% | 5.84% | 11.80% |
Profit Margin | -3.96% | -1.42% | 2.42% | 3.62% | 8.62% |
Free Cash Flow Margin | -11.82% | -15.61% | -9.82% | -15.37% | -0.62% |
EBITDA | 4,791,994 | 4,077,267 | 6,442,673 | 6,329,039 | 7,867,278 |
EBITDA Margin | 10.43% | 8.37% | 11.66% | 12.41% | 18.47% |
D&A For EBITDA | 5,257,905 | 4,682,360 | 3,913,477 | 3,349,685 | 2,840,908 |
EBIT | -465,911 | -605,093 | 2,529,196 | 2,979,354 | 5,026,370 |
EBIT Margin | -1.01% | -1.24% | 4.58% | 5.84% | 11.80% |
Effective Tax Rate | - | - | 17.31% | 22.93% | 25.26% |
Advertising Expenses | 71,108 | 85,898 | 78,480 | 49,546 | 39,055 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.